Financial Avengers’s Bristol-Myers Squibb BMY Stock Holding History

Financial Avengers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.45K	Buy	139 +1	+0.7%	+$58	﹤0.01%	114
2025 Q4	$7.43K	Buy	138 +2	+1%	+$96	﹤0.01%	114
2025 Q3	$6.13K	Buy	136 +2	+1%	+$93	﹤0.01%	121
2025 Q2	$6.2K	Buy	134 +2	+2%	+$98	﹤0.01%	119
2025 Q1	$8.07K	Buy	132 +1	+0.8%	+$58	﹤0.01%	117
2024 Q4	$7.41K	Buy	131 +1	+0.8%	+$56	﹤0.01%	131
2024 Q3	$6.71K	Buy	130 +2	+2%	+$94	﹤0.01%	145
2024 Q2	$5.32K	Buy	128 +2	+2%	+$89	﹤0.01%	130
2024 Q1	$6.69K	Buy	126 +1	+0.8%	+$51	﹤0.01%	118
2023 Q4	$6.4K	Buy	125 +2	+2%	+$105	﹤0.01%	130
2023 Q3	$7.16K	Buy	123 +1	+0.8%	+$61	﹤0.01%	125
2023 Q2	$7.82K	Buy	122 +1	+0.8%	+$67	0.01%	115
2023 Q1	$8.4K	Buy	121 +1	+0.8%	+$71	0.01%	115
2022 Q4	$8.66K	Buy	120 +1	+0.8%	+$75	0.01%	110
2022 Q3	$8K	Hold	119	–	–	0.01%	105
2022 Q2	$9K	Buy	119 +1	+0.8%	+$76	0.01%	112
2022 Q1	$9K	Buy	118 +1	+0.9%	+$67	0.01%	118
2021 Q4	$7K	Buy	117 +1	+0.9%	+$59	﹤0.01%	130
2021 Q3	$7K	Buy	116 +1	+0.9%	+$66	﹤0.01%	127
2021 Q2	$8K	Buy	115 +1	+0.9%	+$65	0.01%	124
2021 Q1	$7K	Buy	114 +1	+0.9%	+$62	0.01%	129
2020 Q4	$7K	Buy	+113	New	+$6.95K	0.01%	126

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Financial Avengers's BMY Position: Q1 2026 in Review

Financial Avengers increased its Bristol-Myers Squibb (BMY) stake by 0.72% in Q1 2026, buying an estimated $58 and bringing the position to 139 shares worth $8.45K. The position accounts for ﹤0.01% of the portfolio, ranked #114.

Financial Avengers first reported a position in BMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $9K in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Financial Avengers held 139 shares of Bristol-Myers Squibb worth $8.45K as of Q1 2026.
Financial Avengers bought 1 Bristol-Myers Squibb share in Q1 2026, an estimated $58.
Bristol-Myers Squibb made up ﹤0.01% of Financial Avengers's portfolio in Q1 2026, its #114 holding.
Financial Avengers first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 22 quarters since.
Financial Avengers's Bristol-Myers Squibb position peaked at $9K in Q2 2022.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Financial Avengers's 13F filing for Q1 2026, filed 19 May 2026.